Hubei Biocause Pharmaceutical (000627) — Cash Flow Reinvestment Rate
Hubei Biocause Pharmaceutical (000627) has a Cash Flow Reinvestment Rate of 35.61x as of September 2023, reinvesting CN¥9.83 Billion (capex CN¥10.51 Million plus investments CN¥-9.82 Billion) from operating cash flow of CN¥276.06 Million. Explore 000627 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hubei Biocause Pharmaceutical Cash Flow Reinvestment Rate (2001–2023)
Historical reinvestment intensity for Hubei Biocause Pharmaceutical across 16 annual periods. Also explore Hubei Biocause Pharmaceutical asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Hubei Biocause Pharmaceutical (2001–2023)
Year-by-year capital reinvestment analysis for Hubei Biocause Pharmaceutical. For live market cap and broader valuation context, see 000627 market cap.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.39x | CN¥3.71 Billion | CN¥9.53 Billion | CN¥67.53 Million | ▼ -81.4% |
| 2022 | 2.09x | CN¥15.75 Billion | CN¥7.52 Billion | CN¥135.06 Million | ▼ -64.4% |
| 2021 | 5.88x | CN¥24.52 Billion | CN¥4.17 Billion | CN¥287.13 Million | ▲ +854.9% |
| 2020 | 0.62x | CN¥13.18 Billion | CN¥21.42 Billion | CN¥319.51 Million | ▼ -60.7% |
| 2019 | 1.57x | CN¥44.77 Billion | CN¥28.60 Billion | CN¥717.10 Million | ▲ +38.1% |
| 2018 | 1.13x | CN¥16.99 Billion | CN¥14.98 Billion | CN¥274.67 Million | ▼ -97.2% |
| 2017 | 40.64x | CN¥17.54 Billion | CN¥431.58 Million | CN¥778.95 Million | ▲ +3589.5% |
| 2013 | 1.10x | CN¥143.80 Million | CN¥130.53 Million | CN¥143.80 Million | ▼ -19.6% |
| 2012 | 1.37x | CN¥128.50 Million | CN¥93.79 Million | CN¥128.50 Million | ▼ -38.6% |
| 2011 | 2.23x | CN¥149.37 Million | CN¥66.95 Million | CN¥149.37 Million | ▲ +438.3% |
| 2010 | 0.41x | CN¥93.09 Million | CN¥224.58 Million | CN¥93.09 Million | ▼ -24.1% |
| 2007 | 0.55x | CN¥64.76 Million | CN¥118.56 Million | CN¥64.76 Million | ▼ -46.2% |
| 2006 | 1.02x | CN¥130.12 Million | CN¥128.19 Million | CN¥130.12 Million | ▲ +101.5% |
| 2005 | 0.50x | CN¥24.51 Million | CN¥48.66 Million | CN¥24.51 Million | ▲ +10.7% |
| 2004 | 0.46x | CN¥25.52 Million | CN¥56.07 Million | CN¥25.52 Million | ▼ -46.0% |
| 2001 | 0.84x | CN¥31.47 Million | CN¥37.30 Million | CN¥31.47 Million | — |